-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FqyKj6WUafPRyQq2RRqosE84lrU9olMtg+Hmf6hoBolWMnBNAN3EUqji3Wc5E+Gp YGkuaaCA6lFBmyO9oZcVow== 0001127602-11-004849.txt : 20110210 0001127602-11-004849.hdr.sgml : 20110210 20110210170742 ACCESSION NUMBER: 0001127602-11-004849 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110209 FILED AS OF DATE: 20110210 DATE AS OF CHANGE: 20110210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOHAPATRA SURYA N CENTRAL INDEX KEY: 0001222671 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 11593471 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2011-02-09 0001022079 QUEST DIAGNOSTICS INC DGX 0001222671 MOHAPATRA SURYA N C/O QUEST DIAGNOSTICS INCORPORATED 3 GIRALDA FARMS MADISON NJ 07940 1 1 Chairman, President & CEO Common Stock 2011-02-09 4 M 0 152000 35.5325 A 449046 D Common Stock 2011-02-09 4 S 0 152000 57.5337 D 297046 D Common Stock 5165 I 401(k)/sdcp Stock Options (Right to Buy) 35.5325 2011-02-09 4 M 0 152000 0 D 2012-02-27 Common Stock 152000 0 D The options vested in three installments beginning with the first on April 17, 2003, the second on February 27, 2004 and the final on February 27, 2005. This transaction was executed in multiple trades at prices ranging from $57.36 to $57.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company stock as of that date. /s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Surya N. Mohapatra 2011-02-10 -----END PRIVACY-ENHANCED MESSAGE-----